First Naturally-designed and Personalised Bioprosthesis SingValve

(Ad)) Professor Theo Kofidis led a team that developed SingValve, a personalised mitral valve bioprosthesis. SingValve mimics a human mitral valve’s appearance and properties, based on patient scans. Awarded α USD 3.6 million (SGD 4.9 million) grant from the National Research Foundation Singapore (NRF), the project will advance through product verification and validation. First-in-human trials are expected by 2023. Singvalve aims to revolutionise heart valve surgery, boosting Singapore’s
MedTech industry and medical tourism.